de Jong EMGJ - Search Results

1

Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis: A Randomized Clinical Trial.

Atalay S, van den Reek JMPA, den Broeder AA, van Vugt LJ, Otero ME, Njoo MD, Mommers JM, Ossenkoppele PM, Koetsier MI, Berends MA, van de Kerkhof PCM, Groenewoud HMM, Kievit W, de Jong EMGJ. Atalay S, et al. Among authors: de jong emgj. JAMA Dermatol. 2020 Apr 1;156(4):393-400. doi: 10.1001/jamadermatol.2019.4897. JAMA Dermatol. 2020. PMID: 32049319 Free PMC article. Clinical Trial.

2

The inter-relation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene-B4--an immunohistochemical study.

de Jong EM, van Erp PE, van Vlijmen IM, van de Kerkhof PC. de Jong EM, et al. Clin Exp Dermatol. 1992 Nov;17(6):413-20. doi: 10.1111/j.1365-2230.1992.tb00249.x. Clin Exp Dermatol. 1992. PMID: 1336720

3

Topical application of dithranol on normal skin induces epidermal hyperproliferation and increased Ks8.12 binding.

de Zwart AJ, de Jong EM, van de Kerkhof PC. de Zwart AJ, et al. Skin Pharmacol. 1992;5(1):34-40. doi: 10.1159/000211015. Skin Pharmacol. 1992. PMID: 1374264

4

Topical application of 13-cis-retinoic acid in the treatment of chronic plaque psoriasis.

Bischoff R, De Jong EM, Rulo HF, Sendagorta E, Czarnetzki BM, Van de Kerkhof PC. Bischoff R, et al. Clin Exp Dermatol. 1992 Jan;17(1):9-12. doi: 10.1111/j.1365-2230.1992.tb02523.x. Clin Exp Dermatol. 1992. PMID: 1424269 Clinical Trial.

5

Markers for proliferation and keratinization in the margin of the active psoriatic lesion.

de Mare S, de Jong E, Van Erp PE, Van de Kerkhof PC. de Mare S, et al. Br J Dermatol. 1990 Apr;122(4):469-75. doi: 10.1111/j.1365-2133.1990.tb14723.x. Br J Dermatol. 1990. PMID: 1692474

6

Inflammatory linear verrucous epidermal naevus (ILVEN) versus linear psoriasis. A clinical, histological and immunohistochemical study.

de Jong E, Rulo HF, van de Kerkhof PC. de Jong E, et al. Acta Derm Venereol. 1991;71(4):343-6. Acta Derm Venereol. 1991. PMID: 1718120

7

Clinical and biochemical effects of an oral leukotriene biosynthesis inhibitor (MK886) in psoriasis.

de Jong EM, van Vlijmen IM, Scholte JC, Buntinx A, Friedman B, Tanaka W, van de Kerkhof PC. de Jong EM, et al. Skin Pharmacol. 1991;4(4):278-85. doi: 10.1159/000210962. Skin Pharmacol. 1991. PMID: 1724166 Clinical Trial.

8

Keratin 17: a useful marker in anti-psoriatic therapies.

de Jong EM, van Vlijmen IM, van Erp PE, Ramaekers FC, Troyanovski SM, van de Kerkhof PC. de Jong EM, et al. Arch Dermatol Res. 1991;283(7):480-2. doi: 10.1007/BF00371788. Arch Dermatol Res. 1991. PMID: 1724898 No abstract available.

9

Immunohistochemical detection of proliferation and differentiation in discoid lupus erythematosus.

de Jong EM, van Erp PE, Ruiter DJ, van de Kerkhof PC. de Jong EM, et al. J Am Acad Dermatol. 1991 Dec;25(6 Pt 1):1032-8. doi: 10.1016/0190-9622(91)70303-j. J Am Acad Dermatol. 1991. PMID: 1725780

10

Topical treatment with the vitamin D3 analogue MC903 improves pityriasis rubra pilaris: clinical and immunohistochemical observations.

van de Kerkhof PC, de Jong EM. van de Kerkhof PC, et al. Br J Dermatol. 1991 Sep;125(3):293-4. doi: 10.1111/j.1365-2133.1991.tb14762.x. Br J Dermatol. 1991. PMID: 1911337 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

315 results

Search Page